Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Horizon Therapeutics (NQ: HZNP ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 116.33 (2) Ask (Size) 116.37 (25) Prev. Close 116.30 Today's Range N/A - N/A 52wk Range 112.10 - 116.27 Shares Outstanding 228,994,568 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Stocks to Buy Low Today With High Hopes for Tomorrow April 15, 2024 Amgen, Canadian Solar, and Diana Shipping are three undervalued stocks with high potential for growth that can enhance portfolio returns. Via InvestorPlace Rule 17(e) Announcement - Horizon Therapeutics plc October 06, 2023 From Horizon Therapeutics plc Via Business Wire Performance More News Read More Peering Into Horizon Therapeutics's Recent Short Interest October 05, 2023 Via Benzinga Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High October 05, 2023 Via Investor Brand Network Rule 17(d) Announcement – Horizon Therapeutics plc October 05, 2023 From Horizon Therapeutics plc Via Business Wire Here's How Much $100 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth Today October 04, 2023 Via Benzinga Horizon Therapeutics PLC (NASDAQ: HZNP) Climbs to New 52-Week High October 03, 2023 Via Investor Brand Network How Is The Market Feeling About Horizon Therapeutics? September 18, 2023 Via Benzinga $1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth This Much Today September 12, 2023 Via Benzinga Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) October 03, 2023 From Horizon Therapeutics plc Via Business Wire Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) October 02, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 October 02, 2023 From Horizon Therapeutics plc Via Business Wire Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) September 29, 2023 From Horizon Therapeutics plc Via Business Wire New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes September 29, 2023 From Horizon Therapeutics plc Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session September 28, 2023 Via Benzinga Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) September 27, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics PLC (NASDAQ: HZNP) Sets New 52-Week High in Tuesday Session September 26, 2023 Via Investor Brand Network Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry September 26, 2023 From Horizon Therapeutics plc Via Business Wire Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) September 25, 2023 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List September 19, 2023 From Horizon Therapeutics plc Via Business Wire Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata September 13, 2023 From Horizon Therapeutics plc Via Business Wire These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts September 13, 2023 Via Benzinga The 3 Most Undervalued Biotech Stocks to Buy in September 2023 September 12, 2023 Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session September 11, 2023 Via Benzinga Horizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement September 06, 2023 From Horizon Therapeutics plc Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.